{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381699995164538368.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Maurizio Cesari"}],"foaf:familyName":[{"@value":"Cesari"}],"foaf:givenName":[{"@value":"Maurizio"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361699995164538368","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1097/00004872-200205000-00002"},{"@type":"URI","@value":"http://journals.lww.com/00004872-200205000-00002"}],"notation":[{"@value":"Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1097/00004872-200205000-00002_KYSL2XMsxSy29lCXPTZ33oFJxFY"}]}